Consensus on laboratory diagnosis of congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
10.3760/cma.j.cn511374-20230330-00178
- Author:
Yu SUN
1
;
Lingqian WU
;
Lei YE
;
Wenjuan QIU
;
Yongguo YU
;
Xuefan GU
Author Information
1. Department of Pediatric Endocrinology/Genetics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China. yuyongguo@shsmu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Child;
Humans;
Adrenal Hyperplasia, Congenital/genetics*;
Steroid 21-Hydroxylase/genetics*;
Consensus;
China;
Clinical Laboratory Techniques;
Mutation
- From:
Chinese Journal of Medical Genetics
2023;40(7):769-780
- CountryChina
- Language:Chinese
-
Abstract:
21 hydroxylase deficiency (21-OHD), the most common form of congenital adrenal hyperplasia, is caused by defects in CYP21A2 gene, which encodes the cytochrome P450 oxidase (P450C21) involved in glucocorticoid and mineralocorticoid synthesis. The diagnosis of 21-OHD is based on the comprehensive evaluation of clinical manifestation, biochemical alteration and molecular genetics results. Due to the complex structure of CYP21A2, special techniques are required to perform delicate analysis to avoid the interference of its pseudogene. Recently, the state-of-the-art diagnostic methods were applied to the clinic gradually, including the steroid hormone profiling and third generation sequencing. To standardize the laboratory diagnosis of 21-OHD, this consensus was drafted on the basis of the extensive knowledge, the updated progress and the published consensuses and guidelines worldwide by expert discussion organized by Rare Diseases Group of Pediatric Branch of Chinese Medical Association, Medical Genetics Branch of Chinese Medical Doctor Association, Birth Defect Prevention and Molecular Genetics Branch of China Maternal and Child Health Association. and Molecular Diagnosis Branch of Shanghai Medical Association.
